Intratympanic corticosteroid for sudden hearing loss: does it really work?

Detalhes bibliográficos
Autor(a) principal: Barreto,Monique Antunes de Souza Chelminski
Data de Publicação: 2016
Outros Autores: Ledesma,Aleluia Lima Losno, Oliveira,Carlos Augusto Costa Pires de, Bahmad Jr,Fayez
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Otorhinolaryngology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942016000300353
Resumo: ABSTRACT INTRODUCTION: Sudden deafness is characterized by an abrupt hearing loss of at least 30 dB in three sequential frequencies in the standard pure tone audiogram over three days or less. Treatment is based on its etiology, and oral corticosteroids are widely used. Intratympanic corticosteroids are included as primary or secondary treatment when there is no improvement with the use of oral corticosteroids. OBJECTIVE: To determine the effectiveness of therapy with intratympanic steroids in sudden deafness. METHODS: A systematic review was performed of publications on the topic in the databases of PubMed/MEDLINE, with the keywords: sudden deafness, sudden hearing loss, and corticosteroids. RESULTS: Thirty scientific studies were analyzed. As to the objectives of the study analyzed, 76.7% sought to evaluate the use of intratympanic therapy salvage after failure to conventional treatment, and intratympanic therapy was used as the primary treatment 23.3% of the studies. CONCLUSION: Intratympanic corticosteroid therapy is prescribed primarily when there is failure of conventional therapy and when it is limited to use systemic corticosteroids, such as the diabetic patient.
id ABORL-F-1_27ac61f0d601c26f698fc54e0e4a3bda
oai_identifier_str oai:scielo:S1808-86942016000300353
network_acronym_str ABORL-F-1
network_name_str Brazilian Journal of Otorhinolaryngology
repository_id_str
spelling Intratympanic corticosteroid for sudden hearing loss: does it really work?Sudden hearing lossSudden deafnessCorticosteroidsABSTRACT INTRODUCTION: Sudden deafness is characterized by an abrupt hearing loss of at least 30 dB in three sequential frequencies in the standard pure tone audiogram over three days or less. Treatment is based on its etiology, and oral corticosteroids are widely used. Intratympanic corticosteroids are included as primary or secondary treatment when there is no improvement with the use of oral corticosteroids. OBJECTIVE: To determine the effectiveness of therapy with intratympanic steroids in sudden deafness. METHODS: A systematic review was performed of publications on the topic in the databases of PubMed/MEDLINE, with the keywords: sudden deafness, sudden hearing loss, and corticosteroids. RESULTS: Thirty scientific studies were analyzed. As to the objectives of the study analyzed, 76.7% sought to evaluate the use of intratympanic therapy salvage after failure to conventional treatment, and intratympanic therapy was used as the primary treatment 23.3% of the studies. CONCLUSION: Intratympanic corticosteroid therapy is prescribed primarily when there is failure of conventional therapy and when it is limited to use systemic corticosteroids, such as the diabetic patient.Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.2016-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942016000300353Brazilian Journal of Otorhinolaryngology v.82 n.3 2016reponame:Brazilian Journal of Otorhinolaryngologyinstname:Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)instacron:ABORL-CCF10.1016/j.bjorl.2015.06.007info:eu-repo/semantics/openAccessBarreto,Monique Antunes de Souza ChelminskiLedesma,Aleluia Lima LosnoOliveira,Carlos Augusto Costa Pires deBahmad Jr,Fayezeng2016-06-27T00:00:00Zoai:scielo:S1808-86942016000300353Revistahttp://www.bjorl.org.br/https://old.scielo.br/oai/scielo-oai.phprevista@aborlccf.org.br||revista@aborlccf.org.br1808-86861808-8686opendoar:2016-06-27T00:00Brazilian Journal of Otorhinolaryngology - Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)false
dc.title.none.fl_str_mv Intratympanic corticosteroid for sudden hearing loss: does it really work?
title Intratympanic corticosteroid for sudden hearing loss: does it really work?
spellingShingle Intratympanic corticosteroid for sudden hearing loss: does it really work?
Barreto,Monique Antunes de Souza Chelminski
Sudden hearing loss
Sudden deafness
Corticosteroids
title_short Intratympanic corticosteroid for sudden hearing loss: does it really work?
title_full Intratympanic corticosteroid for sudden hearing loss: does it really work?
title_fullStr Intratympanic corticosteroid for sudden hearing loss: does it really work?
title_full_unstemmed Intratympanic corticosteroid for sudden hearing loss: does it really work?
title_sort Intratympanic corticosteroid for sudden hearing loss: does it really work?
author Barreto,Monique Antunes de Souza Chelminski
author_facet Barreto,Monique Antunes de Souza Chelminski
Ledesma,Aleluia Lima Losno
Oliveira,Carlos Augusto Costa Pires de
Bahmad Jr,Fayez
author_role author
author2 Ledesma,Aleluia Lima Losno
Oliveira,Carlos Augusto Costa Pires de
Bahmad Jr,Fayez
author2_role author
author
author
dc.contributor.author.fl_str_mv Barreto,Monique Antunes de Souza Chelminski
Ledesma,Aleluia Lima Losno
Oliveira,Carlos Augusto Costa Pires de
Bahmad Jr,Fayez
dc.subject.por.fl_str_mv Sudden hearing loss
Sudden deafness
Corticosteroids
topic Sudden hearing loss
Sudden deafness
Corticosteroids
description ABSTRACT INTRODUCTION: Sudden deafness is characterized by an abrupt hearing loss of at least 30 dB in three sequential frequencies in the standard pure tone audiogram over three days or less. Treatment is based on its etiology, and oral corticosteroids are widely used. Intratympanic corticosteroids are included as primary or secondary treatment when there is no improvement with the use of oral corticosteroids. OBJECTIVE: To determine the effectiveness of therapy with intratympanic steroids in sudden deafness. METHODS: A systematic review was performed of publications on the topic in the databases of PubMed/MEDLINE, with the keywords: sudden deafness, sudden hearing loss, and corticosteroids. RESULTS: Thirty scientific studies were analyzed. As to the objectives of the study analyzed, 76.7% sought to evaluate the use of intratympanic therapy salvage after failure to conventional treatment, and intratympanic therapy was used as the primary treatment 23.3% of the studies. CONCLUSION: Intratympanic corticosteroid therapy is prescribed primarily when there is failure of conventional therapy and when it is limited to use systemic corticosteroids, such as the diabetic patient.
publishDate 2016
dc.date.none.fl_str_mv 2016-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942016000300353
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942016000300353
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjorl.2015.06.007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.
publisher.none.fl_str_mv Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.
dc.source.none.fl_str_mv Brazilian Journal of Otorhinolaryngology v.82 n.3 2016
reponame:Brazilian Journal of Otorhinolaryngology
instname:Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)
instacron:ABORL-CCF
instname_str Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)
instacron_str ABORL-CCF
institution ABORL-CCF
reponame_str Brazilian Journal of Otorhinolaryngology
collection Brazilian Journal of Otorhinolaryngology
repository.name.fl_str_mv Brazilian Journal of Otorhinolaryngology - Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)
repository.mail.fl_str_mv revista@aborlccf.org.br||revista@aborlccf.org.br
_version_ 1754575991820255232